Clinical Trial: Study of PTC844 in Participants With Active Rheumatoid Arthritis

U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779616) titled 'Study of PTC844 in Participants With Active Rheumatoid Arthritis' on Aug. 18.

Brief Summary: This study is designed to assess the safety, pharmacokinetics (PK), and biomarker effects of PTC844 compared to placebo in participants with active rheumatoid arthritis (RA).

Study Start Date: Aug. 31

Study Type: INTERVENTIONAL

Condition: Rheumatoid Arthritis

Intervention: DRUG: PTC844

PTC844 will be administered per schedule specified in the arm description.

DRUG: Placebo

Placebo matching to PTC844 will be administered per schedule specified in the arm description.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: PTC Therapeutics...